FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2801658809> ?p ?o ?g. }

• W2801658809 endingPage "1182" @default.
• W2801658809 startingPage "1171" @default.
• W2801658809 abstract "Concurrent chemoradiotherapy (CRT) is standard therapy for locally advanced NSCLC (LA-NSCLC) patients. This study was performed to examine thoracic radiotherapy (TRT) parameters and their impact on patient survival.We collected individual patient data from 3600 LA-NSCLC patients participating in 16 cooperative group trials of concurrent CRT. The primary TRT parameters examined included field design strategy (elective nodal irradiation [ENI] compared to involved-field TRT (IF-TRT)), total dose, and biologically effective dose (BED). Hazard ratios (HRs) for overall survival were calculated with univariable and multivariable Cox models.TRT doses ranged from 60 Gy to 74 Gy with most treatments administered once-daily. ENI was associated with poorer survival than IF-TRT (univariable HR = 1.37, 95% confidence interval [CI]: 1.24-1.51, p < 0.0001; multivariable HR = 1.31, 95% CI: 1.08-1.59, p = 0.002). The median survival times of the IF and ENI patients were 24 months and 16 months, respectively. Patients were divided into three dose groups: low total dose (60 Gy), medium total dose (>60 Gy to 66 Gy), and high total dose (>66 Gy to 74 Gy). With reference to the low-dose group, the multivariable HRs were 1.08 for the medium-dose group (95% CI: 0.93-1.25) and 1.12 for the high-dose group (95% CI: 0.97-1.30).The univariate p = 0.054 and multivariable p = 0.17. BED was grouped as follows: low (<55.5 Gy10), medium (55.5 Gy10), or high (>55.5 Gy10). With reference to the low-BED group, the HR was 1.00 (95% CI: 0.85-1.18) for the medium-BED group and 1.10 (95% CI: 0.93-1.31) for the high-BED group. The univariable p = 0.076 and multivariable p = 0.16.For LA-NSCLC patients treated with concurrent CRT, IF-TRT was associated with significantly better survival than ENI-TRT. TRT total and BED dose levels were not significantly associated with patient survival. Future progress will require research focusing on better systemic therapy and TRT." @default.
• W2801658809 created "2018-05-17" @default.
• W2801658809 creator A5014554706 @default.
• W2801658809 creator A5023696543 @default.
• W2801658809 creator A5028702225 @default.
• W2801658809 creator A5032192226 @default.
• W2801658809 creator A5062848479 @default.
• W2801658809 creator A5063904421 @default.
• W2801658809 creator A5074789425 @default.
• W2801658809 creator A5084337375 @default.
• W2801658809 creator A5088178599 @default.
• W2801658809 date "2018-08-01" @default.
• W2801658809 modified "2023-10-01" @default.
• W2801658809 title "Exploring Radiotherapy Targeting Strategy and Dose: A Pooled Analysis of Cooperative Group Trials of Combined Modality Therapy for Stage III NSCLC" @default.
• W2801658809 cites W1548882558 @default.
• W2801658809 cites W1944220675 @default.
• W2801658809 cites W1965125352 @default.
• W2801658809 cites W1968899146 @default.
• W2801658809 cites W1976640734 @default.
• W2801658809 cites W1995801693 @default.
• W2801658809 cites W1995805135 @default.
• W2801658809 cites W2003456733 @default.
• W2801658809 cites W2004764331 @default.
• W2801658809 cites W2009128924 @default.
• W2801658809 cites W2009137891 @default.
• W2801658809 cites W2048819950 @default.
• W2801658809 cites W2051767374 @default.
• W2801658809 cites W2060985892 @default.
• W2801658809 cites W2064947884 @default.
• W2801658809 cites W2068551729 @default.
• W2801658809 cites W2069967644 @default.
• W2801658809 cites W2080654185 @default.
• W2801658809 cites W2096103793 @default.
• W2801658809 cites W2110469369 @default.
• W2801658809 cites W2113966750 @default.
• W2801658809 cites W2116679443 @default.
• W2801658809 cites W2121138562 @default.
• W2801658809 cites W2121774591 @default.
• W2801658809 cites W2134201833 @default.
• W2801658809 cites W2135257379 @default.
• W2801658809 cites W2136887681 @default.
• W2801658809 cites W2143715924 @default.
• W2801658809 cites W2152939220 @default.
• W2801658809 cites W2153865661 @default.
• W2801658809 cites W2155053061 @default.
• W2801658809 cites W2159997815 @default.
• W2801658809 cites W2282423929 @default.
• W2801658809 cites W2317448174 @default.
• W2801658809 cites W2485866634 @default.
• W2801658809 cites W2522150959 @default.
• W2801658809 cites W2531388082 @default.
• W2801658809 cites W2570618306 @default.
• W2801658809 cites W2581615902 @default.
• W2801658809 cites W2612390378 @default.
• W2801658809 cites W2753065806 @default.
• W2801658809 cites W2758584801 @default.
• W2801658809 cites W4211243765 @default.
• W2801658809 cites W4293241248 @default.
• W2801658809 doi "https://doi.org/10.1016/j.jtho.2018.04.011" @default.
• W2801658809 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29689435" @default.
• W2801658809 hasPublicationYear "2018" @default.
• W2801658809 type Work @default.
• W2801658809 sameAs 2801658809 @default.
• W2801658809 citedByCount "15" @default.
• W2801658809 countsByYear W28016588092019 @default.
• W2801658809 countsByYear W28016588092020 @default.
• W2801658809 countsByYear W28016588092021 @default.
• W2801658809 countsByYear W28016588092022 @default.
• W2801658809 countsByYear W28016588092023 @default.
• W2801658809 crossrefType "journal-article" @default.
• W2801658809 hasAuthorship W2801658809A5014554706 @default.
• W2801658809 hasAuthorship W2801658809A5023696543 @default.
• W2801658809 hasAuthorship W2801658809A5028702225 @default.
• W2801658809 hasAuthorship W2801658809A5032192226 @default.
• W2801658809 hasAuthorship W2801658809A5062848479 @default.
• W2801658809 hasAuthorship W2801658809A5063904421 @default.
• W2801658809 hasAuthorship W2801658809A5074789425 @default.
• W2801658809 hasAuthorship W2801658809A5084337375 @default.
• W2801658809 hasAuthorship W2801658809A5088178599 @default.
• W2801658809 hasBestOaLocation W28016588091 @default.
• W2801658809 hasConcept C126322002 @default.
• W2801658809 hasConcept C126894567 @default.
• W2801658809 hasConcept C143998085 @default.
• W2801658809 hasConcept C144301174 @default.
• W2801658809 hasConcept C146357865 @default.
• W2801658809 hasConcept C151730666 @default.
• W2801658809 hasConcept C207103383 @default.
• W2801658809 hasConcept C2778424827 @default.
• W2801658809 hasConcept C2989005 @default.
• W2801658809 hasConcept C38180746 @default.
• W2801658809 hasConcept C44249647 @default.
• W2801658809 hasConcept C50382708 @default.
• W2801658809 hasConcept C509974204 @default.
• W2801658809 hasConcept C71924100 @default.
• W2801658809 hasConcept C86803240 @default.
• W2801658809 hasConceptScore W2801658809C126322002 @default.
• W2801658809 hasConceptScore W2801658809C126894567 @default.
• W2801658809 hasConceptScore W2801658809C143998085 @default.

• next